QUINTESSENTIAL offers a broad range of early development services, including drug discovery and development, Phase I clinical trial services and helping clients increase efficiencies and accelerate the drug discovery and development process. We specialize in planning, execution and analysis of Phase II and Phase III clinical trials. We provide customised services, in PMS and Registry trials. These services can support both global and locally managed projects.
QUINTESSENTIAL provides services for Phase IV clinical trials which are conducted for identifying and evaluating the long-term effects of new drugs and treatments over a lengthy period for a greater number of patients. We offer Phase IV research which takes place after the Regulatory approves the marketing of a new drug. Our team’s eyes on new tested drug continuously to uncover more information about efficacy, safety and side effects after being approved for marketing
Our team members are more intensive and specified, they often test the drugs’ effect on specific demographics. This can include pregnant women or people who are currently taking other medication to see if there is a reaction between the two drugs. Phase IV research is conducted over such an extensive period and on a massive population, long-term and unique effects can be precisely identified and measured. In addition, our team can be conducted to find new markets for competitive analysis on the drug or treatment.